Who owns Forth Therapeutics?

Forth Therapeutics is currently owned by Sofinnova Partners, through Sofinnova Biovelocita I, since 2023.

When did Sofinnova Partners acquire Forth Therapeutics?

Sofinnova Partners acquired Forth Therapeutics in 2023 (active for 3 years).

Home/Companies/Biotech/Forth Therapeutics

Biotech·

Italy·Active·3yr hold

Forth Therapeutics is a healthcare / biotech company, headquartered in Italy.

Entry

2023

Hold

3yr

Status

Active

Est. EV

–

Investor

HQItaly

SectorHealthcare / Biotech

Italian biotech developing precision treatments for fibrosis using multi-omic insights and targeted therapies, part of Biovelocita.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Already a member? Sign in

Other portfolio companies in the same fund.

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings